ZURICH (Reuters) – Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company’s bispecific antibody Glofitamab. Glofitamab is intended for patients…
(Reuters) -The U.S. health regulator on Tuesday issued an emergency use authorization to Roche’s test for the detection of DNA from monkeypox virus in swab specimens collected from people suspected…
By Ludwig Burger FRANKFURT -Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of lung cancer…